Diagnosing Coronary Artery Disease

Diagnosing Coronary Artery Disease

The primary symptom of coronary artery disease (CAD) is chest pain, often associated with breathing difficulties, dizziness or nausea. It is difficult to determine whether chest pain is related to the heart or not.¹ Because of this, healthcare professionals will refer patients to cardiology specialists for increasingly invasive and costly examinations.² The most common steps in diagnosing significant CAD can include general medical examination, exercise ECG, stress imaging, echocardiography, coronary computed tomography angiography (CCTA) and invasive coronary angiogram.

Chest pain is one of the most common reasons patients seek care in an emergency or primary care setting.9,10 However, 9 out of 10 patients with chest pain do not suffer from CAD, resulting in unnecessary diagnostic tests and increased healthcare costs.5,7,8

CADScor®System offers a new approach to early assessment and risk stratify risk stratify of CAD. Physicians now have an easy-to-use, rapid diagnostic aid for patients with chest pain and suspected CAD.

Quickly and easily risk stratify significant CAD with at least 96% Confidence (Negative Predictive Value)*

CADScor® System is a point-of-care diagnostic aid that uses highly sensitive acoustics and advanced computational processing to analyze the patient’s coronary blood flow. The system calculates a patient-specific CAD-score, and couples it with risk factors to rapidly indicate the patient’s risk of significant coronary stenosis for immediate risk stratification, prior to potential secondary evaluation.3 CADScor® System has been used in over 47,000 patient assessments6 and has CE-marking and FDA De Novo clearance.

Learn more about CADScor®System

Use CADScor® System to Risk Stratify Significant CAD in Patients Experiencing Chest Pain or Shortness of Breath*

Non-invasive and radiation free assessment with actionable results

Can help save costs of urgent advance CAD diagnostics in up to 40% of patients3

Allow for immediate risk stratification prior to potential secondary evaluation

CADScor®System Research, Development and Clinical Studies

CADScor®System is approved in Europe with CE-marking and has received FDA De Novo clearance as a diagnostic aid for symptomatic patients with suspected CAD.4 Multiple clinical studies have been published to demonstrate the CADScor®System performance.

View research

Physicians’ Experiences Using CADScor®System

Explore customer feedback

By submitting your information, you confirm you would like to be contacted by Acarix. Read our privacy notice here , if you want to know more about how we treat and protect your personal data.

Schedule a Demo of the
CADScor®System

Schedule a free demo of CADScor®System and learn how you can risk stratify significant CAD at point of care*.
  1. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2021;Oct 28:[Epub ahead of print]. Circulation. 2021 Nov 30;144(22):e368-e454. doi: 10.1161/CIR.0000000000001029. Epub 2021 Oct 28. Erratum in: Circulation. 2021 Nov 30;144(22):e455. PMID: 34709879.
  2. Shaw LJ, Marwick TH, Zoghbi WA, Hundley WG, Kramer CM, Achenbach S, Dilsizian V, Kern MJ, Chandrashekhar Y, Narula J. Why all the focus on cardiac imaging? JACC Cardiovasc Imaging. 2010 Jul;3(7):789-94. doi: 10.1016/j.jcmg.2010.05.004. PMID: 20633864.
  3. User manual US-FDA v.12.Y, prevalence 10,7%
  4. CADScor®System FDA De Novo clearance letter – DEN190047, and CE mark documentation
  5. Winther S, et al. Heart 2018;104:928–935 (Dan-NICAD I)
  6. Based on commercial patch use since 2017
  7. Therming C, et al. Eur Heart J Qual Care Clin Outcomes. 2018; 4:301-308
  8. Douglas et al, N Engl J Med 2015;372:1291-300 (Promise)
  9. Rui P, Kang K. National Hospital Ambulatory Medical Care Survey: 2017 emergency department summary tables. National Center for Health Statistics. Available from: www.cdc.gov/nchs/data/nhamcs/web_tables/2017_ed_web_tables-508.pdf., Hsia RY, Hale Z, Tabas JA. A National Study of the Prevalence of Life-Threatening Diagnoses in Patients With Chest Pain. JAMA Intern Med. 2016;176(7):1029–1032.
  10. Rui P, Okeyode T. National Ambulatory Medical Care Survey: 2016 National Summary Tables. Available from www.cdc.gov/nchs/data/ahcd/namcs_summary/2016_namcs_web_tables.pdf *Rule out with at least 96% confidence (NPV)
  11. Bjerking LH et al. Eur Heart J. Published online September 1, 2024